
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+15
Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies, and rigorous science to develop best-in-class insights for the next generation of precision medicine. Through collaborations with its biopharma partners, Aignostics supports drug discovery, translational research, clinical trials, and CDx development across multiple therapeutic areas. Established in 2018, Aignostics is a spin-off from Charite Berlin, one of the worlds largest and most esteemed university hospitals. Aignostics is funded by leading VC investors and has operations in Berlin and New York
Artificial intelligence,pathology,digital pathology,oncology,immuno-oncology,auto immune disease,neurodegenerative disease,improving medicine,companion diagnostics,precision medicine,solutions,r&d,computational pathology,predictive,deep learning,software engineering,translational research,target identification,healthcare,and biomarkers
Aignostics operates in the Software development industry.
Aignostics's revenue is 11m - 100m
Aignostics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.